Breath of discovery: simple test may sniff out lung cancer

NCT ID NCT07689968

First seen Jul 08, 2026 · Last updated Jul 15, 2026 · Updated 3 times

Summary

This pilot study explores whether a breath sample collected with the VosCryo device can provide enough cellular material to help diagnose advanced lung cancer. Researchers will compare breath samples from 12 people with late-stage lung cancer and 12 healthy relatives to see if the samples can tell the difference between cancerous and non-cancerous states. If successful, this could pave the way for a simple, non-invasive breath test for lung cancer detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
VosCryo breath sample collection device
What this could lead to
If successful, this could lead to a simple, non-invasive breath test to help detect lung cancer, potentially enabling earlier diagnosis.
What could go wrong
This is a very small pilot study with only 24 participants, so results may not be generalizable. The breath sample may not contain enough usable cells for reliable analysis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Weston Park Cancer Centre

    Sheffield, South Yorkshire, S10 2SJ, United Kingdom

    Contact

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.